Company Shaanxi Kanghui Pharmaceutical Co., Ltd.

Company Shaanxi Kanghui Pharmaceutical Co., Ltd.

603139

CNE100002XT3

Pharmaceuticals

Equities

603139

CNE100002XT3

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Generic Pharmaceuticals

SHAANXI KANGHUI PHARMACEUTICAL CO., LTD.

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
14.4 ^CNY	-0.96%		-12.94%	-23.28%

04-26	Shaanxi Kanghui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-15	Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback	MT

SHAANXI KANGHUI PHARMACEUTICAL CO., LTD. is principally engaged in research and development, manufacture and sales of Chinese patent medicines. The Company's main products include Kun Fu Kang capsules (tablets), Fufang Shuanghua tablets, Xiaoyin granules, Fuguigutong capsules, Zhiyao Xiaoke capsules and Fufang Qingdai perfusates. The Company distributes its products just within China domestic market.

Number of employees: 952

CNY in Million	2022	Weight	2023	Weight	Delta
Pharmaceutical Manufacturing 53.0 %	319	64.9 %	352	53.0 %	+10.55%
Pharmaceutical Wholesale 47.0 %	155	31.5 %	312	47.0 %	+101.50%
Inter-segment Elimination -4.9 %	-7	-1.5 %	-33	-4.9 %	+338.99%
Pharmaceutical Intermediate and Others 4.9 %	21	4.2 %	33	4.9 %	+56.71%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	492	100.0 %	673	100.0 %	+36.92%

Managers	Title	Age	Since
Yan Ling Wang CEO	Chief Executive Officer	64	31/12/98
Bin Ze Zou DFI	Director of Finance/CFO	37	10/12/18
Jin Yang BRD	Director/Board Member	48	-
Jing Yi Zhao BRD	Director/Board Member	55	10/12/09
Juan Dong IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
Jian Ping Hou BRD	Director/Board Member	63	10/12/09
Wai Tao Ye BRD	Director/Board Member	51	31/10/12
Yan Ling Wang CEO	Chief Executive Officer	64	31/12/98
Jing Yi Zhao BRD	Director/Board Member	55	10/12/09
Chao Jun Hao CHM	Chairman	60	10/12/09
Xiang Ding BRD	Director/Board Member	56	10/12/09
Jin Yang BRD	Director/Board Member	48	-
Hong Xu Zhao BRD	Director/Board Member	53	30/11/09
Jian Wei Dou BRD	Director/Board Member	56	15/04/21
Yu Ke Kang BRD	Director/Board Member	66	15/04/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	99,880,000	39,674,337 ( 39.72 %)	0	39.72 %

Name	Equities	%	Valuation
Da Cheng Fund Management Co., Ltd. 0.2844 %	152,500	0.2844 %	293 566 ¥
Western Leadbank Fund Management Co., Ltd 0.0638 %	34,200	0.0638 %	65 836 ¥
China Southern Asset Management Co., Ltd. 0.0397 %	21,300	0.0397 %	41 003 ¥
Sealand Securities Co., Ltd. (Investment Management) 0.0323 %	17,300	0.0323 %	33 303 ¥
Gfund Management Co., Ltd. 0.0265 %	14,200	0.0265 %	27 335 ¥
Nuode Asset Management Co., Ltd. 0.0190 %	10,200	0.0190 %	19 635 ¥
Fortune & Royal Asset Management Co., Ltd. 0.0131 %	7,000	0.0131 %	13 475 ¥

Shaanxi Kanghui Pharmaceutical Co., Ltd.

No. 36 Rouge Road Qindu District

712000, Xianyang

http://www.sxkh.com

address Shaanxi Kanghui Pharmaceutical Co., Ltd.(603139)

	1st Jan change	Capi.
SHAANXI KANGHUI PHARMACEUTICAL CO., LTD.	-23.28%	199M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.63%	44.11B
OTSUKA HOLDINGS CO., LTD.	+23.03%	22.71B
SANDOZ GROUP AG	+18.22%	15.15B
CIPLA LIMITED	+12.66%	13.56B
ZYDUS LIFESCIENCES LIMITED	+60.18%	12.7B
ONO PHARMACEUTICAL CO., LTD.	-10.02%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.92%	5.63B

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals